Literature DB >> 33941809

Age-related iron accumulation and demyelination in the basal ganglia are closely related to verbal memory and executive functioning.

Davina Biel1,2, Tineke K Steiger3, Nico Bunzeck4,5.   

Abstract

Age-related cognitive decline has been linked to alterations of the dopaminergic system and its subcortical trajectories. Recent work suggests a critical role of iron accumulation within the basal ganglia (BG) in verbal memory performance, and increased iron levels have been related to demyelination. However, the specificity of age-related iron increases with respect to cognitive functions remains unclear. Therefore, we investigated the interplay of age, cognitive performance, and structural integrity of the BG. In total, 79 healthy older participants underwent a broad cognitive assessment (fluid and crystallized intelligence, verbal and numeric memory, processing speed, executive functions) and structural MRI. As expected, performance in most cognitive tests had a negative relationship with age. Moreover, BG grey matter volume and magnetization transfer (MT, indicative of myelin) decreased, and R2* (indicative of iron) increased with age. Importantly, R2* and demyelination negatively correlated with verbal memory and executive functions. Within the SN/VTA, age correlated negatively with MT, but there was no clear evidence in favor of a relationship between behavior and R2* or MT. Our results suggest that age-related increases in iron and demyelination within the BG, which are part of a fronto-striatal network, not only impact on verbal memory but also executive functions.

Entities:  

Year:  2021        PMID: 33941809     DOI: 10.1038/s41598-021-88840-1

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  104 in total

Review 1.  Insights into the ageing mind: a view from cognitive neuroscience.

Authors:  Trey Hedden; John D E Gabrieli
Journal:  Nat Rev Neurosci       Date:  2004-02       Impact factor: 34.870

2.  The effect of age on the non-haemin iron in the human brain.

Authors:  B HALLGREN; P SOURANDER
Journal:  J Neurochem       Date:  1958-10       Impact factor: 5.372

3.  Striatal iron content predicts its shrinkage and changes in verbal working memory after two years in healthy adults.

Authors:  Ana M Daugherty; E Mark Haacke; Naftali Raz
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

4.  Age-related differences in iron content of subcortical nuclei observed in vivo: a meta-analysis.

Authors:  Ana Daugherty; Naftali Raz
Journal:  Neuroimage       Date:  2012-12-28       Impact factor: 6.556

5.  MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping.

Authors:  Berkin Bilgic; Adolf Pfefferbaum; Torsten Rohlfing; Edith V Sullivan; Elfar Adalsteinsson
Journal:  Neuroimage       Date:  2011-09-08       Impact factor: 6.556

Review 6.  The relevance of iron in the pathogenesis of Parkinson's disease.

Authors:  Jeswinder Sian-Hülsmann; Silvia Mandel; Moussa B H Youdim; Peter Riederer
Journal:  J Neurochem       Date:  2011-01-31       Impact factor: 5.372

Review 7.  Iron and dopamine: a toxic couple.

Authors:  Dominic J Hare; Kay L Double
Journal:  Brain       Date:  2016-04       Impact factor: 13.501

8.  Regional brain changes in aging healthy adults: general trends, individual differences and modifiers.

Authors:  Naftali Raz; Ulman Lindenberger; Karen M Rodrigue; Kristen M Kennedy; Denise Head; Adrienne Williamson; Cheryl Dahle; Denis Gerstorf; James D Acker
Journal:  Cereb Cortex       Date:  2005-02-09       Impact factor: 5.357

Review 9.  Oligodendrocytes and myelination: the role of iron.

Authors:  Bozho Todorich; Juana M Pasquini; Corina I Garcia; Pablo M Paez; James R Connor
Journal:  Glia       Date:  2009-04-01       Impact factor: 7.452

10.  Iron Level and Myelin Content in the Ventral Striatum Predict Memory Performance in the Aging Brain.

Authors:  Tineke K Steiger; Nikolaus Weiskopf; Nico Bunzeck
Journal:  J Neurosci       Date:  2016-03-23       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.